Camhi SM, Katzmarzyk PT Differences in body composition between metabolically healthy obese and metabolically abnormal obese adults. Int J Obes (Lond). 2014 Aug;38(8):1142-5. doi: 10.1038/ijo.2013.208. Epub 2013 Nov 12.
Camhi SM, Katzmarzyk PT Total and femoral neck bone mineral density and physical activity in a sample of men and women. Appl Physiol Nutr Metab. 2012 Oct;37(5):947-54. doi: 10.1139/h2012-075. Epub 2012 Jul 23.
Katzmarzyk PT, Greenway FL, Heymsfield SB, Bouchard C Clinical utility and reproducibility of visceral adipose tissue measurements derived from dual-energy X-ray absorptiometry in White and African American adults. Obesity (Silver Spring). 2013 Nov;21(11
Katzmarzyk PT, Heymsfield SB, Bouchard C Clinical utility of visceral adipose tissue for the identification of cardiometabolic risk in white and African American adults. Am J Clin Nutr. 2013 Mar;97(3):480-6. doi: 10.3945/ajcn.112.047787. Epub 2013 Jan 30
Katzmarzyk PT, Hu G, Cefalu WT, Mire E, Bouchard C The importance of waist circumference and BMI for mortality risk in diabetic adults. Diabetes Care. 2013 Oct;36(10):3128-30. doi: 10.2337/dc13-0219. Epub 2013 Jun 11.
Katzmarzyk PT, Mire E, Bouchard C Abdominal obesity and mortality: The Pennington Center Longitudinal Study. Nutr Diabetes. 2012 Aug 27;2(8):e42. doi: 10.1038/nutd.2012.15.
Staiano AE, Bouchard C, Katzmarzyk PT BMI-specific waist circumference thresholds to discriminate elevated cardiometabolic risk in White and African American adults. Obes Facts. 2013;6(4):317-24. doi: 10.1159/000354712. Epub 2013 Aug 9.
Sullivan R, Johnson WD, Katzmarzyk PT Waist circumference is an independent correlate of errors in self-reported BMI. Obesity (Silver Spring). 2010 Nov;18(11):2237-9. doi: 10.1038/oby.2010.178. Epub 2010 Aug 19.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
